Bionano Genomics Inc BNGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.36
- Day Range
- $1.36–1.41
- 52-Week Range
- $1.01–2.23
- Bid/Ask
- $1.40 / $1.42
- Shares Outstanding
- 11.78M
- Market Cap
- $16.49M
- Volume/Avg
- 33,327 / 903,226
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 97
- Website
- https://www.bionano.com
Valuation
|
Metric
|
BNGO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.51 |
Price/Sales | 0.43 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNGO
|
|---|---|
Quick Ratio | 1.42 |
Current Ratio | 2.48 |
Interest Coverage | −24.34 |
Quick Ratio
BNGO
Profitability
|
Metric
|
BNGO
|
|---|---|
Return on Assets (Normalized) | −41.88% |
Return on Equity (Normalized) | −68.44% |
Return on Invested Capital (Normalized) | −50.57% |
Return on Assets
BNGO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|@!%l@j< | LOCK|J%V | $149B | |||
| Becton Dickinson & Co
BDX
| LOCK|?#P | LOCK|xYyy | $51B | |||
| ResMed Inc
RMD
| LOCK|$<>sJQ% | LOCK|jN%w | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|w$Vw%w | LOCK|?t^! | $31B | |||
| Alcon Inc
ALC
| LOCK|XKp^<& | LOCK|#^P%q | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|QtQ^bc> | LOCK|@Tk | $26B | |||
| Solventum Corp
SOLV
| LOCK|c>S%N> | LOCK|DC | $15B | |||
| Baxter International Inc
BAX
| LOCK|>#w | LOCK|%hws | $13B | |||
| Repligen Corp
RGEN
| LOCK|@ghkHPng | LOCK|?!B>x | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|kl<<%L | LOCK|sCs@ | $10B |
United States